New Obesity Target Expression and Purification Service
InquiryThe global landscape of metabolic research is shifting from simple GLP-1 receptor agonists to complex multi-receptor synergists and novel intracellular signaling targets. As the pharmaceutical industry seeks the next generation of therapeutics—targeting pathways like SCOR2 inhibition, GIP/glucagon co-agonism, and adipocyte thermogenesis—the demand for high-purity, structurally intact recombinant proteins has never been higher.
Precision Recombinant Protein Solutions for Next-Generation Obesity Therapeutics
Protheragen provides a specialized new obesity target expression and purification service designed to bridge the gap between genomic discovery and robust preclinical validation. We deliver "assay-ready" proteins that maintain native folding and post-translational modifications, essential for high-throughput screening and structural biology.
Core Technologies
To overcome the inherent instability and low expression levels of many metabolic targets, Protheragen utilizes a suite of proprietary platforms:
A high-throughput screening system that tests dozens of host-strain and chaperone combinations simultaneously to identify the optimal environment for difficult-to-express metabolic enzymes.
Specialized for targets that frequently form inclusion bodies, ensuring the recovery of bioactive proteins through controlled, gradient-based dialysis and molecular chaperone assistance.
A detergent-free or mild-detergent approach for expressing G-protein coupled receptors (GPCRs) and other membrane-bound obesity targets, preserving the lipid-protein interface necessary for ligand binding.
Utilization of cleavable, high-solubility fusion tags that facilitate rapid purification without interfering with the target protein's downstream biological activity.
Solution Scope
Protheragen offers the most comprehensive protein production suite for obesity research, focusing exclusively on the preclinical stage:
- GPCR Production
Expression and purification of GLP-1, GIP, and glucagon receptors, including specialized stabilization for structural studies (Cryo-EM/X-ray).
- Metabolic Enzyme Synthesis
Production of intracellular targets involved in fatty acid oxidation, lipid synthesis (e.g., ACC, FASN), and thermogenic regulators.
- Incretin Mimetics & Fusion Proteins
Engineering of multi-specific peptides and protein-Fc fusions designed for extended half-life studies in animal models.
- Adipokine & Myokine Panels
Customized production of signaling molecules like Leptin, Adiponectin, and irisin for paracrine signaling research.
- Custom Isotope Labeling
Delivery of 15N, 13C, or 2H labeled proteins for NMR-based structural determination and ligand-binding site mapping.
Contact us to accelerate your next-generation metabolic research breakthroughs.
Workflow
Our streamlined preclinical workflow ensures that every project transitions seamlessly from sequence optimization to the delivery of high-purity protein.
Fields of Application
Our screening services are essential for various stages of preclinical development:
- High-Throughput Screening (HTS): Developing robust assays for identifying novel small molecules or biologics that modulate weight-loss targets.
- Structural Biology: Providing high-concentration, monodisperse protein samples for Cryo-EM and X-ray crystallography to resolve drug-target interfaces.
- Surface Plasmon Resonance (SPR): Measuring precise kinetic constants (KD, kon, koff) for lead optimization.
- Preclinical Animal Formulation: Supplying bulk quantities of bioactive proteins for chronic dosing studies in obesity models.
Advantages
Partnering with Protheragen provides your drug discovery pipeline with unparalleled technical precision and reliability.
High Conformational Integrity
Our proteins are validated for correct folding, ensuring that your in vitro binding data translates accurately to in vivo efficacy.
Low Endotoxin Standards
We guarantee ultra-low endotoxin levels (<0.1 EU/µg), critical for preventing non-specific inflammatory responses in metabolic cell assays.
Rapid Turnaround
Our automated platforms allow us to move from gene synthesis to purified protein in as little as 4–6 weeks for standard targets.
Proven Track Record
Our purified GLP-1R extracellular domains have demonstrated superior binding affinity compared to industry standards, facilitating more sensitive screening of small-molecule modulators.
Contact Our Team to Accelerate Your Metabolic Pipeline Today.
Customer Review
Overcoming GPCR Complexity for Breakthrough Lead Discovery
"The complexity of our novel GPCR target for obesity was causing significant bottlenecks in our screening program. Protheragen was able to deliver stabilized, high-purity protein where others failed. Their Membrane-X™ technology preserved the receptor's activity, allowing us to identify three promising lead compounds in record time. We are already planning our next series of targets with their team."
Dr. A. R., Director of Discovery, Biopharmaceutical Lead
High-Yield Production of Ultra-Pure Metabolic Enzymes
"Protheragen's technical expertise in metabolic enzymes is unmatched. They provided us with gram quantities of a difficult-to-express thermogenic regulator with endotoxin levels so low that our in vivo results were incredibly clean. Their transparent communication and detailed QC reports give us total confidence in our preclinical data. They are a vital extension of our R&D department."
Dr. C. B., Scientist, Metabolic Health Institute
Frequently Asked Questions
-
What expression systems do you recommend for GPCRs?
We typically recommend mammalian (HEK293) or insect cell systems to ensure proper post-translational modifications and membrane insertion.
-
Can you produce proteins with specific post-translational modifications?
Yes, our mammalian platforms are optimized for complex glycosylation and phosphorylation required for metabolic signaling.
-
What is the minimum purity you guarantee?
Our standard purification target is >95% by SDS-PAGE and SEC-HPLC, though we can reach >98% for structural applications.
-
Do you handle the gene synthesis portion of the project?
Absolutely. We provide end-to-end services from digital sequence to purified protein.
-
How do you ensure the protein is active?
We perform routine functional validation, such as ligand-binding assays or enzymatic activity tests, depending on the target.
-
Can you scale up for large-scale animal studies?
Yes, we have the capacity to produce gram-scale quantities of high-purity recombinant proteins.
-
Do you offer tag-free protein delivery?
Yes, we utilize site-specific proteases (e.g., TEV, SUMO) to remove affinity tags, leaving the native sequence.
-
How do you stabilize unstable obesity targets?
We employ proprietary buffer screening and the addition of specific ligands or lipids to maintain protein stability during and after purification.
-
What is your experience with multi-specific fusion proteins?
We have extensive experience expressing bi- and tri-specific scaffolds designed for dual or triple metabolic agonism.
Contact Us
Protheragen is your premier partner for the expression and purification of next-generation obesity targets. By combining cutting-edge biotechnology with a deep understanding of metabolic science, we empower researchers to explore new therapeutic frontiers with confidence and speed. Welcome to Contact Protheragen to discuss your project requirements.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.